These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 4471026)
1. Interferon: its expectations for the future. Galasso GJ In Vitro Monogr; 1974; (3):66-9. PubMed ID: 4471026 [No Abstract] [Full Text] [Related]
2. [Prevention and therapy of virus diseases with interferon]. Neumann-Haefelin D Dtsch Med Wochenschr; 1977 May; 102(20):766-72. PubMed ID: 862525 [No Abstract] [Full Text] [Related]
3. Interferon tolerance and antiviral protection in mice given single or multiple injections of endotoxin or poly I : C. Giron DJ; Schmidt JP; Pindak FF; Connell JE Acta Virol; 1973 May; 17(3):209-14. PubMed ID: 4147139 [No Abstract] [Full Text] [Related]
4. Induction of interferons in vivo by ds-RNAs from natural sources. Planterose DN Tex Rep Biol Med; 1977; 35():99-104. PubMed ID: 358478 [No Abstract] [Full Text] [Related]
5. Interferons: therapeutic prospects. Finter NB Mod Trends Med Virol; 1970; 2(0):262-83. PubMed ID: 4950660 [No Abstract] [Full Text] [Related]
6. [Artificial polynucleotides as inducers of interferon]. Heidel G Z Gesamte Hyg; 1974 Feb; 20(2):116. PubMed ID: 4598964 [No Abstract] [Full Text] [Related]
7. [Interferon and its inducers]. de Maeyer-Guignard J Rev Prat; 1979 Aug; 29(37):2929-33. PubMed ID: 118508 [No Abstract] [Full Text] [Related]
8. Clinical testing of human interferon in infectious diseases. Merigan TC In Vitro Monogr; 1974; (3):57-62. PubMed ID: 4377883 [No Abstract] [Full Text] [Related]
9. Interferon, an antiviral drug for use in man. Myers M; Galasso G Tex Rep Biol Med; 1981-1982; 41():543-8. PubMed ID: 6189221 [No Abstract] [Full Text] [Related]
10. [Recent research progress on interferon]. Azuma K Hokkaido Igaku Zasshi; 1982 Mar; 57(2):139-46. PubMed ID: 6180965 [No Abstract] [Full Text] [Related]
12. [Therapeutic activity of catleukocyte interferon in the treatment of viral diseases of the genitclia and several aspects of the body's resistance of malignization]. Simeonova L; Simeonov S; Arnaudova V Akush Ginekol (Sofiia); 1976; 15(3):216-9. PubMed ID: 1033683 [No Abstract] [Full Text] [Related]
13. [Interferon and other antiviral agents, especially those concerning influenza: memorandum]. Bull World Health Organ; 1978; 56(5):753-65. PubMed ID: 310718 [No Abstract] [Full Text] [Related]
14. [Present interest and limits of human interferon in therapeutics]. Fauconnier B Bull Acad Natl Med; 1981 Mar; 165(3):395-8. PubMed ID: 6173106 [No Abstract] [Full Text] [Related]
15. Recent advances in the study of interferon. Ho M Pharmacol Rev; 1982 Mar; 34(1):119-29. PubMed ID: 6175986 [No Abstract] [Full Text] [Related]
16. Interferons and interferon inducers: development of clinical usefulness and therapeutic promise. Pollard RB Drugs; 1982; 23(1-2):37-55. PubMed ID: 6173188 [No Abstract] [Full Text] [Related]
18. Interferon: its inducers and some aspects of host resistance in malignancy. Merigan TC Cancer Chemother Rep; 1974; 58(4):571-8. PubMed ID: 4604626 [No Abstract] [Full Text] [Related]
19. [Interferons and their importance for prevention and therapy in man and animals]. Selbitz HJ; Scheel H; Voigt A; Schönherr W Z Gesamte Inn Med; 1980 Dec; 35(23):837-41. PubMed ID: 6162290 [TBL] [Abstract][Full Text] [Related]
20. A review of approaches to viral chemotherapy. Gordon M; Buchanan RL; Crenshaw RR; Kerridge KA; MacNintch JE; Siminoff P J Med; 1981; 12(5):289-382. PubMed ID: 6171603 [No Abstract] [Full Text] [Related] [Next] [New Search]